Back to top

Hikma Pharmaceuticals (HIK) Initiated with a Buy at Citi

Citi analyst initiated coverage with a Buy rating on Hikma Pharmaceuticals today and set a price target of £17.00. Currently, the analyst consensus...

Read full article here »

In-Depth Zacks Research for the Tickers Above

Normally $25 each - click below to receive one report FREE:

Hikma Pharmaceuticals Plc (HKMPF)